HIP
ADMA icon

HUB Investment Partners’s ADMA Biologics ADMA Stock Holding History

HUB Investment Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,560
Closed -$338K – 823
2025
Q2 		$338K Buy
18,560
+2,892
+18% +$59K 0.01% 485
2025
Q1 		$311K Buy
15,668
+5,556
+55% +$96.1K 0.01% 439
2024
Q4 		$173K Sell
10,112
-5,238
-34% -$98.5K 0.01% 516
2024
Q3 		$307K Sell
15,350
-1,996
-12% -$31K 0.01% 376
2024
Q2 		$194K Sell
17,346
-513
-3% -$4.3K 0.01% 448
2024
Q1 		$118K Buy
+17,859
New +$97.6K 0.01% 455

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HUB Investment Partners's ADMA Position: Q3 2025 in Review

HUB Investment Partners sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 18,560 shares — an estimated $338K sold.

HUB Investment Partners first reported a position in ADMA in Q1 2024 and held it in 6 quarters. The position peaked at $338K in Q2 2025. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • HUB Investment Partners reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • HUB Investment Partners sold 18,560 ADMA Biologics shares in Q3 2025, an estimated $338K.
  • HUB Investment Partners first reported a position in ADMA Biologics in Q1 2024 and held it in 6 quarters.
  • HUB Investment Partners's ADMA Biologics position peaked at $338K in Q2 2025.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on HUB Investment Partners's 13F filing for Q3 2025, filed 12 Nov 2025.